Expanding CRISPR-Edited Cells
Expand CRISPR-edited cells to generate sufficient, high-quality cell populations for downstream characterization, functional validation and gene therapy process development. While expanding cultures, track cell counts and viability using a Beckman Coulter Life Sciences Vi-CELL BLU Cell Viability Analyzer. Characterize cellular metabolism and culture performance using mass spectrometry, including differential mass analysis using a SCIEX Triple Quad 7500 System. Automate and integrate analysis of metabolomics and cell-based measurements, as well as track all cell line batches, using the Genedata Biopharma Platform to enable data traceability, comparability and scalable workflow management.